We are here to make a difference

Redefining cancer detection

quote

“Asima Health is developing a highly-sensitive, early detection, multi-cancer blood test to reduce the human and financial burden of cancer testing...

webdesign-GB-03

non-invasive

Our innovative technology can quickly rule out cancer or identify those at risk and in need of colonoscopy, mammography, etc., with a simple blood test.

webdesign-GB-04

accessible

Our platform technology is portable which means that the test can be accessed through your local diagnostic lab, as part of routine blood work.

webdesign-GB-01

multi-cancer

Our pan-genomic test can simultaneously detect multiple cancers which means primary & secondary cancers can be caught from a single blood draw.

MEET ASIMA HEALTH

Early cancer detection can save lives

cancer diagnosis doctor and patient - edit
Cancer survivorship

More people are surviving cancer. Between 1991 & 2020, the death rate for all cancers in the U.S. declined by 33%. Currently there are 18 million cancer survivors in the U.S and this number is projected to become 26 million by 2040.

Patient,And,Doctor,In,Hospital,During,Colonoscopy,,Closeup
Survivor challenges

Cancer survivors follow up with their doctor every 3-12 mos for a physical exam & testing. The standard of care involves tests such as mammograms and colonoscopy, that are invasive, expensive, slow to get results, and have low diagnostic yield.

Did you know?

Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide.

OUR partners

longevity tech
velocity
Screenshot 2025-06-23 at 12.03.36 PM
innovation factory
Indian_Institute_of_Technology_Delhi_Logo.svg
OICR Logo (CNW Group/Providence Therapeutics)
IP ON
NRC Canada
IP institute canada
101 genai